iBio
IBIO
$1.97
Share price
-2.84%
Change (1 day)
79.35%
Change (1 year)
Categories
Earnings for iBio (IBIO)
Earnings in 2023 (TTM): -$20.67 M
According to iBio's latest financial reports the company's current earnings (TTM) are -$20.67 M. an increase over its 2022 earnings that were of -$41.65 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for iBio from 2008 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$20.67 M | -50.39% |
| 2022 | -$41.65 M | 122.23% |
| 2021 | -$18.74 M | -12.52% |
| 2020 | -$21.43 M | 45% |
| 2019 | -$14.78 M | -3.71% |
| 2018 | -$15.35 M | 5.52% |
| 2017 | -$14.54 M | 18.82% |
| 2016 | -$12.24 M | 60.34% |
| 2015 | -$7.64 M | 38.31% |
| 2014 | -$5.52 M | 25.01% |
| 2013 | -$4.42 M | |
| 2010 | -$12.24 M | 360.89% |
| 2009 | -$2.66 M | 5.77% |
| 2008 | -$2.52 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -82,245.10% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | -$37.2 M | 80.01% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -$0.28 B | 1,237.09% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.65 B | 3,016.02% | 🇺🇸 USA |